Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules
Reexamination Certificate
2011-06-28
2011-06-28
Wax, Robert A (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Capsules
C514S338000
Reexamination Certificate
active
07968118
ABSTRACT:
An anti-acid pharmaceutical composition for the rapid and prolonged neutralization of gastric acidity with mucosa-protecting activity in powder form to prepare, by dispersion in water, a pharmaceutical solution or suspension for oral use characterized in that the composition includes sodium alginate; an anti-acid soluble agent or a combination of anti-acids; an inhibitor of proton pump; diluent and sweetening agents, wherein a) at least 30% of sodium alginate present in the formulation along with the total of the inhibitor of proton pump are homogeneously distributed over the surface of the total soluble anti-acid agent of the combination of anti-acids of the composition; and b) the rest, about 70%, of sodium alginate present in the formulation contains a percentage of humidity of less than 2%.
REFERENCES:
patent: 4744986 (1988-05-01), Luber et al.
patent: 4786505 (1988-11-01), Lovgren et al.
patent: 6183776 (2001-02-01), Depui et al.
patent: 0813424 (2002-11-01), None
patent: 2189698 (1987-11-01), None
patent: 98/23272 (1998-06-01), None
patent: 2004/089340 (2004-10-01), None
patent: 2005/007117 (2005-01-01), None
patent: 2005/032554 (2005-04-01), None
patent: WO 2005032554 (2005-04-01), None
Derwent ACC-No. 2005-296044.
A.M. Sakr et al., Effect of the Technique of Incorporating Sodium Alignate on Its Binding and/or Disintegrating Effectiveness in Sulfathiazole Tablets, Pharm Ind., 1978, pp. 1080-1086, 40 (10), Asyot, Egypt.
A. Pilbrant et al., Development of an oral formulation of omeprazole, Scandinavian Journal of Gastroenterology, 1985, pp. 113-120, 20 (Suppl. 108), Sweden.
Per Lindberg et al., The Mechanism of Action of the Gastric Acid Secretion Inhibitor Omeprazole, Journal of Medicinal Chemistry, 1986, pp. 1327-1329, vol. 29, No. 8, The American Chemical Society.
Sir Colin Dollery et al., Therapeutic Drugs—Omeprazole, 1991, pp. O17-O20, vol. 2, 1st edition, Churchill Livinstone, United Kingdom.
Robert A. Quercia et al., Stability of omeprazole in an extemporaneously prepared oral liquid, Am J Health-Syst Pharm, Aug. 15, 1997, pp. 1833-1836, vol. 54, American Society of Health-System Pharmacists, Inc.
Jeffrey O. Phillips et al., A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage, Crit Care Med, 1996, pp. 1793-1800, vol. 24, No. 11, Williams & Wilkins.
Dr. Jose Rafael Blengio Pinto et al., Comparacion de las propiedades de los antagonistas de los receptores H2 de histamina, Goodman & Gilman, Las Bases Famacologicas De La Terapeutica, 2003, p. 1025, Volumen 1, Decima Edicion, McGraw Hill, Argentina.
Gaviscon Infant, mims—Monthly Index of Medical Specialists, Sep. 2001, p. 14, Eisai Ltd.
Man Tang et al., Bioadhesive oesophageal bandages: protection against acid and pepsin injury, international journal of pharmaceutics, 2005, pp. 169-177, vol. 292, Elsevier B.V., United Kingdom.
Gaviscon Advance, Summary of Product Characteristics last updated on the eMC: Sep. 19, 2005, Forum Health Products Limited, United Kingdom.
K.G. Mandel et al., Review article: alginate-raft formulations in the treatment of heartburn and acid reflux, Aliment Pharmacol Ther 2000, Jan. 12, 2000, pp. 669-690, vol. 14, Blackwell Science Ltd., U.S.A.
Yajaman Sudhakar et al., Buccal bioadhesive drug delivery—a promising option for orally less efficient drugs, Journal of Controlled Release, 2006, pp. 15-40, vol. 114, Issue 1, Elsevier B.V.—Abstract Only.
European Search Report for European Patent Application No. 07 38 0159, dated Apr. 10, 2008.
Al-Awadi Danah
Bachman & LaPointe P.C.
Laboratorios Bago S.A.
Wax Robert A
LandOfFree
Anti-acid pharmaceutical composition in powder form and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-acid pharmaceutical composition in powder form and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-acid pharmaceutical composition in powder form and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2658132